Christopher M Verdier
Examiner (ID: 1476, Phone: (571)272-4824 , Office: P/3745 )
Most Active Art Unit | 3745 |
Art Unit(s) | 3401, 2851, 3745, 2899 |
Total Applications | 2960 |
Issued Applications | 2317 |
Pending Applications | 150 |
Abandoned Applications | 493 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 13127393
[patent_doc_number] => 10081617
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-25
[patent_title] => Factor XIa inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/565748
[patent_app_country] => US
[patent_app_date] => 2016-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38162
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 305
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15565748
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/565748 | Factor XIa inhibitors | Apr 10, 2016 | Issued |
Array
(
[id] => 11025016
[patent_doc_number] => 20160221970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-04
[patent_title] => 'NOVEL COMPOUNDS AND COMPOSITIONS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 15/094166
[patent_app_country] => US
[patent_app_date] => 2016-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 45344
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15094166
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/094166 | NOVEL COMPOUNDS AND COMPOSITIONS AND METHODS OF USE | Apr 7, 2016 | Abandoned |
Array
(
[id] => 12009647
[patent_doc_number] => 09802953
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-31
[patent_title] => 'Intermediates and methods for the synthesis of halichondrin B analogs'
[patent_app_type] => utility
[patent_app_number] => 15/092850
[patent_app_country] => US
[patent_app_date] => 2016-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17107
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15092850
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/092850 | Intermediates and methods for the synthesis of halichondrin B analogs | Apr 6, 2016 | Issued |
Array
(
[id] => 13035227
[patent_doc_number] => 10039726
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-07
[patent_title] => Identification of stabilizers of multimeric proteins
[patent_app_type] => utility
[patent_app_number] => 15/092446
[patent_app_country] => US
[patent_app_date] => 2016-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 32
[patent_no_of_words] => 20663
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15092446
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/092446 | Identification of stabilizers of multimeric proteins | Apr 5, 2016 | Issued |
Array
(
[id] => 14132233
[patent_doc_number] => 20190100506
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-04
[patent_title] => Pyrrole Derivatives
[patent_app_type] => utility
[patent_app_number] => 16/091781
[patent_app_country] => US
[patent_app_date] => 2016-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10231
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16091781
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/091781 | Pyrrole derivatives | Apr 5, 2016 | Issued |
Array
(
[id] => 14057783
[patent_doc_number] => 10233175
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-19
[patent_title] => Pyridinium compounds
[patent_app_type] => utility
[patent_app_number] => 15/564715
[patent_app_country] => US
[patent_app_date] => 2016-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8412
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15564715
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/564715 | Pyridinium compounds | Apr 4, 2016 | Issued |
Array
(
[id] => 13236935
[patent_doc_number] => 10131658
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-20
[patent_title] => Anti-alphavbeta1 integrin compounds and methods
[patent_app_type] => utility
[patent_app_number] => 15/083836
[patent_app_country] => US
[patent_app_date] => 2016-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 19
[patent_no_of_words] => 34958
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 377
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15083836
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/083836 | Anti-alphavbeta1 integrin compounds and methods | Mar 28, 2016 | Issued |
Array
(
[id] => 13236935
[patent_doc_number] => 10131658
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-20
[patent_title] => Anti-alphavbeta1 integrin compounds and methods
[patent_app_type] => utility
[patent_app_number] => 15/083836
[patent_app_country] => US
[patent_app_date] => 2016-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 19
[patent_no_of_words] => 34958
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 377
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15083836
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/083836 | Anti-alphavbeta1 integrin compounds and methods | Mar 28, 2016 | Issued |
Array
(
[id] => 14518869
[patent_doc_number] => 10336681
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-02
[patent_title] => Process for the synthesis of dialkyl carbonates
[patent_app_type] => utility
[patent_app_number] => 15/560821
[patent_app_country] => US
[patent_app_date] => 2016-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 6550
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15560821
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/560821 | Process for the synthesis of dialkyl carbonates | Mar 22, 2016 | Issued |
Array
(
[id] => 12219149
[patent_doc_number] => 20180057505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-01
[patent_title] => 'BICYCLIC HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF THE PAR-2 SIGNALING PATHWAY'
[patent_app_type] => utility
[patent_app_number] => 15/559761
[patent_app_country] => US
[patent_app_date] => 2016-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 152374
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15559761
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/559761 | BICYCLIC HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF THE PAR-2 SIGNALING PATHWAY | Mar 18, 2016 | Abandoned |
Array
(
[id] => 11876712
[patent_doc_number] => 09748495
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-29
[patent_title] => 'Carbazole derivative, light-emitting element material, light-emitting element, light-emitting device, electronic device, and lighting device'
[patent_app_type] => utility
[patent_app_number] => 15/071727
[patent_app_country] => US
[patent_app_date] => 2016-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 41
[patent_no_of_words] => 18997
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15071727
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/071727 | Carbazole derivative, light-emitting element material, light-emitting element, light-emitting device, electronic device, and lighting device | Mar 15, 2016 | Issued |
Array
(
[id] => 11075685
[patent_doc_number] => 20160272649
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-22
[patent_title] => 'DIAMINE DERIVATIVES AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE'
[patent_app_type] => utility
[patent_app_number] => 15/069484
[patent_app_country] => US
[patent_app_date] => 2016-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 94761
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15069484
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/069484 | DIAMINE DERIVATIVES AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE | Mar 13, 2016 | Abandoned |
Array
(
[id] => 10987315
[patent_doc_number] => 20160184260
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-30
[patent_title] => 'METHODS FOR PURIFYING TRANS-(-)-DELTA9-TETRAHYDROCANNABINOL AND TRANS-(+)-DELTA9-TETRAHYDROCANNABINOL'
[patent_app_type] => utility
[patent_app_number] => 15/061780
[patent_app_country] => US
[patent_app_date] => 2016-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19382
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15061780
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/061780 | Methods for purifying trans-(−)-Δ9-tetrahydrocannabinol and trans-(+)-Δ9-tetrahydrocannabinol | Mar 3, 2016 | Issued |
Array
(
[id] => 11677075
[patent_doc_number] => 09675581
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-13
[patent_title] => 'Methods for purifying trans-(−)-Δ9-tetrahydrocannabinol and trans- (+)-Δ9-tetrahydrocannabinol'
[patent_app_type] => utility
[patent_app_number] => 15/061859
[patent_app_country] => US
[patent_app_date] => 2016-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19472
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15061859
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/061859 | Methods for purifying trans-(−)-Δ9-tetrahydrocannabinol and trans- (+)-Δ9-tetrahydrocannabinol | Mar 3, 2016 | Issued |
Array
(
[id] => 11002395
[patent_doc_number] => 20160199344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-14
[patent_title] => 'METHODS FOR PURIFYING TRANS-(-)-Δ9-TETRAHYDROCANNABINOL AND TRANS-(+)-Δ9 TETRAHYDROCANNABINOL'
[patent_app_type] => utility
[patent_app_number] => 15/061891
[patent_app_country] => US
[patent_app_date] => 2016-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19390
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15061891
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/061891 | METHODS FOR PURIFYING TRANS-(-)-Δ9-TETRAHYDROCANNABINOL AND TRANS-(+)-Δ9 TETRAHYDROCANNABINOL | Mar 3, 2016 | Abandoned |
Array
(
[id] => 12178641
[patent_doc_number] => 20180037578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-08
[patent_title] => 'METHOD FOR PRODUCING 1,2,4-OXADIAZOLE DERIVATIVE'
[patent_app_type] => utility
[patent_app_number] => 15/556221
[patent_app_country] => US
[patent_app_date] => 2016-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9288
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15556221
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/556221 | Method for producing 1,2,4-oxadiazole derivative | Mar 2, 2016 | Issued |
Array
(
[id] => 12231833
[patent_doc_number] => 20180064696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-08
[patent_title] => 'TRICYCLIC ANALOGUES, PREPARATION METHOD AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/556932
[patent_app_country] => US
[patent_app_date] => 2016-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15491
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15556932
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/556932 | Tricyclic analogues, preparation method and uses thereof | Mar 2, 2016 | Issued |
Array
(
[id] => 12178592
[patent_doc_number] => 20180037528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-08
[patent_title] => 'TREATMENT METHOD, COMPOUNDS, AND METHOD OF INCREASING TRPV2 ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 15/550561
[patent_app_country] => US
[patent_app_date] => 2016-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 12713
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15550561
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/550561 | TREATMENT METHOD, COMPOUNDS, AND METHOD OF INCREASING TRPV2 ACTIVITY | Feb 25, 2016 | Abandoned |
Array
(
[id] => 12158776
[patent_doc_number] => 20180030043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-01
[patent_title] => 'NOVEL PROCESS FOR THE PREPARATION OF 1,3-THIAZOL-5-YLMETHYL [(2R,5R)-5- CARBAMOYL) AMINO] -4-(MORPHOLIN-4-YL)BUTANOYL]AMINO}-1,6-DIPHENYLHEXAN-2-YL]CARBAMATE'
[patent_app_type] => utility
[patent_app_number] => 15/551856
[patent_app_country] => US
[patent_app_date] => 2016-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14697
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15551856
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/551856 | Process for the preparation of 1,3-thiazol-5-ylmethyl [(2R,5R)-5-{[(2s)-2-[(methyl{[2-(propan-2-yl)-1,3-thiazol-4YL] methyl} carbamoyl) amino]-4-(morpholin-4-yl)butanoyl]amino)-1,6-diphenylhexan-2-yl]carbamate | Feb 16, 2016 | Issued |
Array
(
[id] => 10805208
[patent_doc_number] => 20160151364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-02
[patent_title] => '4-IMIDAZOPYRIDAZIN-1-YL-BENZAMIDES AND 4-IMIDAZOTRIAZIN-1-YL-BENZAMIDES AS BTK INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/019543
[patent_app_country] => US
[patent_app_date] => 2016-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28442
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15019543
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/019543 | 4-imidazopyridazin-1-yl-benzamides as Btk inhibitors | Feb 8, 2016 | Issued |